Healthcare provider profile · identity verified

Tiffini Smith, NP

Nurse Practitioner · FISHERS, IN · NPI 1093209348

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	393	81
Amlodipine Besylate	Amlodipine Besylate	297	60
Levothyroxine Sodium	Levothyroxine Sodium	262	51
Metoprolol Succinate	Metoprolol Succinate	235	39
Pantoprazole Sodium	Pantoprazole Sodium	181	36
Sertraline Hcl	Sertraline Hcl	177	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	175	62
Omeprazole	Omeprazole	175	45
Losartan Potassium	Losartan Potassium	174	32
Furosemide	Furosemide	170	50
Tramadol Hcl	Tramadol Hcl	147	38
Duloxetine Hcl	Duloxetine Hcl	141	31
Gabapentin	Gabapentin	138	50
Trazodone Hcl	Trazodone Hcl	136	55
Eliquis	Apixaban	130	33
Metoprolol Tartrate	Metoprolol Tartrate	128	18
Lisinopril	Lisinopril	121	23
Metformin Hcl	Metformin Hcl	118	21
Tamsulosin Hcl	Tamsulosin Hcl	113	26
Potassium Chloride	Potassium Chloride	105	24
Farxiga	Dapagliflozin Propanediol	99	17
Famotidine	Famotidine	96	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	19
Donepezil Hcl	Donepezil Hcl	95	18
Oxycodone Hcl	Oxycodone Hcl	89	30
Divalproex Sodium	Divalproex Sodium	87	16
Lorazepam	Lorazepam	79	20
Meloxicam	Meloxicam	77	suppressed
Alendronate Sodium	Alendronate Sodium	74	14
Carvedilol	Carvedilol	74	25
Olanzapine	Olanzapine	73	suppressed
Myrbetriq	Mirabegron	72	suppressed
Buspirone Hcl	Buspirone Hcl	71	20
Ondansetron Hcl	Ondansetron Hcl	69	23
Rosuvastatin Calcium	Rosuvastatin Calcium	69	16
Fludrocortisone Acetate	Fludrocortisone Acetate	68	suppressed
Xarelto	Rivaroxaban	66	suppressed
Rivastigmine	Rivastigmine Tartrate	65	suppressed
Mirtazapine	Mirtazapine	64	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	suppressed
Warfarin Sodium	Warfarin Sodium	61	13
Levetiracetam	Levetiracetam	57	12
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Fluticasone Propionate	Fluticasone Propionate	56	23
Torsemide	Torsemide	55	18
Single Use Swab	Alcohol Antiseptic Pads	54	14
Albuterol Sulfate Hfa	Albuterol Sulfate	53	37
Montelukast Sodium	Montelukast Sodium	53	15
Pregabalin	Pregabalin	53	12
Clopidogrel	Clopidogrel Bisulfate	51	21
Loperamide	Loperamide Hcl	48	24
Escitalopram Oxalate	Escitalopram Oxalate	47	16
Hydrochlorothiazide	Hydrochlorothiazide	47	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	47	13
Quetiapine Fumarate	Quetiapine Fumarate	47	13
Cephalexin	Cephalexin	46	22
Nuedexta	Dextromethorphan Hbr/Quinidine	46	suppressed
Memantine Hcl	Memantine Hcl	45	12
Clonidine	Clonidine	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	11
Simvastatin	Simvastatin	43	suppressed
Clonazepam	Clonazepam	42	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	42	suppressed
Ammonium Lactate	Ammonium Lactate	41	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	24
Latanoprost	Latanoprost	39	suppressed
Spironolactone	Spironolactone	38	12
Ezetimibe	Ezetimibe	37	suppressed
Baclofen	Baclofen	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Allopurinol	Allopurinol	32	12
Finasteride	Finasteride	32	suppressed
Risperidone	Risperidone	32	suppressed
Divalproex Sodium Er	Divalproex Sodium	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	15
Prednisone	Prednisone	31	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	18
Vitamin D2	Ergocalciferol (Vitamin D2)	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Lidocaine	Lidocaine	26	12
Methocarbamol	Methocarbamol	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Anastrozole	Anastrozole	25	suppressed
Atenolol	Atenolol	25	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Klor-Con 10	Potassium Chloride	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Aripiprazole	Aripiprazole	24	suppressed
Nystatin	Nystatin	24	17
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Insulin Lispro	Insulin Lispro	22	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	16
Irbesartan	Irbesartan	20	suppressed
Nitroglycerin	Nitroglycerin	20	17
Bethanechol Chloride	Bethanechol Chloride	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Desmopressin Acetate	Desmopressin Acetate	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Lidocaine Hcl	Lidocaine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Tradjenta	Linagliptin	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Levofloxacin	Levofloxacin	15	11
Metformin Hcl Er	Metformin Hcl	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Glipizide	Glipizide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	13
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Piroxicam	Piroxicam	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Invokana	Canagliflozin	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error